ISSN 1016-5169 | E-ISSN 1308-4488
pdf
Cangrelor Monotherapy Bridging for Cardiac and Non-Cardiac Surgery Following Percutaneous Coronary Intervention [Turk Kardiyol Dern Ars]
Turk Kardiyol Dern Ars. Ahead of Print: TKDA-86987 | DOI: 10.5543/tkda.2024.86987

Cangrelor Monotherapy Bridging for Cardiac and Non-Cardiac Surgery Following Percutaneous Coronary Intervention

Spyridon-filippos Papadopoulos1, Emmanouela Peteinidou1, Konstantinos C. Theodoropoulos1, Matthaios Didagelos1, Athanasios Samaras2, Aristi Boulmpou3, Thomas Gossios1, Antonios Kouparanis1, George Kassimis2, Antonios Ziakas1
1First Cardiology Department, AHEPA General University Hospital, Aristotle University of Thessaloniki, Greece
2Second Cardiology Department, Hippokration University Hospital of Thessaloniki, Thessaloniki, Greece
3Third Cardiology Department, Hippokration University Hospital of Thessaloniki, Thessaloniki, Greece

Management of dual antiplatelet therapy (DAPT) perioperatively is challenging, especially in patients with recent percutaneous coronary intervention (PCI). Intravenous antiplatelet agents are suggested in this scenario. In this case series, we describe the perioperative management of two high bleeding risk patients with a recent PCI undergoing cardiac and non-cardiac surgery, using cangrelor monotherapy.

Keywords: Bridging therapy, cangrelor, DAPT, surgery

Corresponding Author: Konstantinos C. Theodoropoulos
Manuscript Language: English
×
APA
NLM
AMA
MLA
Chicago
Copied!
CITE


Journal Metrics

Journal Citation Indicator: 0.18
CiteScore: 1.1
Source Normalized Impact
per Paper:
0.22
SCImago Journal Rank: 0.348

Quick Search

Copyright © 2024 Archives of the Turkish Society of Cardiology



Kare Publishing is a subsidiary of Kare Media.